Loading viewer...
investor_presentation
Format: PDF investor_presentation
Full-year 2023 financial results and performance review presented on February 22, 2024. Covers financial highlights, business strategy overview, and 2024 prospects with presentations by CEO Padma Ravichander and CFO Indiresh Vivekananda.
investor_presentation
18 Pages
Energen
Iovance Biotherapeutics Investor Presentation — January 2019
investor_presentationinvestor_presentation
34 Pages
Iovance Biotherapeutics, Inc